ctrlK

INCY

Nasdaq

INCYTE CORP

Health Care, Biotechnology

$120.56

close 7 Aug 2026

+52.24%

52-week change

$24.11B

market cap

$78.20
$132.60

52-week range

Line itemTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11FY10FY09
Income
Revenue$5.36B$5.14B$4.24B$3.70B$3.39B$2.99B$2.67B$2.16B$1.88B$1.54B$1.11B$753.75M$511.50M$354.95M$297.06M$94.46M$169.88M$9.27M
Cost of revenue$403.47M$372.13M$312.07M$254.99M$207.00M$150.99M$131.33M$114.25M$94.12M$79.48M$58.19M$26.97M$3.00M$630.00K$157.00K
Gross profit
R&D$2.13B$2.05B$2.61B$1.63B$1.59B$1.46B$2.22B$1.15B$1.20B$1.33B$581.86M$479.51M$347.52M$260.44M$210.39M$178.71M$123.88M$119.44M
SG&A$1.38B$1.38B$1.24B$1.16B$1.00B$739.56M$516.92M$468.71M$434.41M$366.29M$303.25M$196.61M$165.77M$109.98M$85.36M$58.22M$32.33M$27.58M
Operating income$1.61B$1.51B$61.37M$620.53M$579.44M$585.78M-$263.68M$402.01M$129.22M-$243.39M$145.00M$50.65M-$4.80M-$16.10M$1.15M-$143.18M$14.05M-$139.77M
Interest expense$2.34M$2.43M$2.28M$2.55M$2.67M$1.91M$2.17M$1.86M$1.54M$6.90M$38.75M$45.60M$46.83M$38.65M$46.06M$43.82M$43.32M$32.13M
Tax expense$342.08M$377.80M$284.02M$236.62M$188.46M-$378.14M$63.48M$39.89M$5.85M$852.00K$3.18M$1.03M-$66.00K$299.00K$174.00K
Net income$1.43B$1.29B$32.62M$597.60M$340.66M$948.58M-$295.70M$446.91M$109.49M-$313.14M$104.22M$6.53M-$48.48M-$83.15M-$44.32M-$186.54M-$31.85M-$211.87M
Diluted EPS$7.08$6.41$0.1500$2.65$1.52$4.27-$1.36$2.05$0.5100-$1.53$0.5400$0.0300-$0.2900-$0.5600
Gross margin
Operating margin30.05%29.46%1.45%16.79%17.07%19.62%-9.89%18.62%6.87%-15.84%13.11%6.72%-0.94%-4.54%0.39%-151.59%8.27%-1,508.56%
Net margin26.71%25.03%0.77%16.17%10.04%31.76%-11.09%20.70%5.82%-20.38%9.43%0.87%-9.48%-23.43%-14.92%-197.49%-18.75%-2,286.78%

filed 28 Apr 2026